期刊文献+

丙戊酸在癫痫患者中的血清药物浓度/剂量比影响因素研究 被引量:3

Research on Influencing Factors of Serum Valproic Acid Concentration/Dose Ratio in Patients with Epilepsy
下载PDF
导出
摘要 目的:研究癫痫患者的性别、年龄、体重、联合用药及合并疾病对丙戊酸血清浓度/剂量比(concentration/dose,C/D)的影响。方法:回顾性分析2018年5月至2019年8月某院进行丙戊酸血清浓度监测的癫痫患者77例,将性别、年龄、体重、联合用药、合并疾病、日剂量和血清药物浓度等信息录入Excel表,计算C/D值,采用SPSS 22.0软件进行统计分析。结果:年龄<6岁、6~<12岁、12~<18岁、18~<60岁及≥60岁患者的丙戊酸C/D分别为(192.80±106.44)、(113.37±53.36)、(64.77±33.67)(60.34±23.82)及(84.80±21.50)ng·d/(mg·ml),差异有统计学意义(P<0.05)。体重<22 kg、22~35 kg及>35 kg患者的丙戊酸C/D分别为(176.41±114.75)、(134.61±43.76)及(63.12±27.26)ng·d/(mg·ml),差异有统计学意义(P<0.05)。而性别、联合用药及合并疾病对丙戊酸C/D无影响。结论:<12岁(尤其<6岁)的儿童以及体重≤35 kg的患者,需适当减少丙戊酸剂量,谨防发生不良反应。 OBJECTIVE:To investigate the effects of gender,age,weight,drug combination and concomitant disease on serum drug concentration/dose ratio(C/D)of valproic acid in patients with epilepsy.METHOD:77 patients with epilepsy who were monitored for serum drug concentration of valproic acid in a certain hospital from May 2018 to Aug.2019 were retrospectively analyzed.Information including gender,age,weight,drug combination,concomitant disease,daily dose and serum drug concentration were entered into the Excel table to calculate C/D values.SPSS 22.0 was adopted to conduct statistical analysis.RESULTS:The C/D values of patients aged<6 years,6-<12 years,12-<18 years,18-<60 years,≥60 years were respectively(192.80±106.44),(113.37±53.36),(64.77±33.67),(60.34±23.82)and(84.80±21.50)ng·d/(mg·ml),with statistically significant differences(P<0.05).The C/D values of patients weighed<22 kg,22-35 kg and>35 kg were respectively(176.41±114.75),(134.61±43.76)and(63.12±27.26)ng·d/(mg·ml),with statistically significant differences(P<0.05).Gender,drug combination and concomitant disease had no effects on the C/D values.CONCLUSIONS:Children age<12 years old(especially<6 years old)and patients weighed≤35 kg need to reduce the dose of valproic acid appropriately to prevent adverse drug reactions.
作者 曾晓云 林子琦 葛冰琛 阙富昌 周本杰 ZENG Xiaoyun;LIN Ziqi;GE Bingchen;QUE Fuchang;ZHOU Benjie(Dept. of Pharmacy, the Seventh Affiliated Hospital of Sun Yat-sen University, Guangdong Shenzhen 518107, China;School of Pharmacy, Guangdong Medical University, Guangdong Dongguan 523808, China)
出处 《中国医院用药评价与分析》 2020年第8期914-916,919,共4页 Evaluation and Analysis of Drug-use in Hospitals of China
基金 广东省医院药学研究基金(No.2019A01)。
关键词 丙戊酸 血清药物浓度/剂量比 影响因素 年龄 体重 Valproic acid Serum drug concentration/dose ratio Influencing factor Age Weight
  • 相关文献

参考文献4

二级参考文献32

  • 1孙妍萍,谭兰,王雁,宋敬卉.尿苷二磷酸葡萄糖醛酸转移酶1A6基因多态性对丙戊酸钠代谢的影响[J].中华医学杂志,2007,87(29):2033-2035. 被引量:10
  • 2Ghodke-Puranik Y, Thom CF, Lamba JK,eZ al. Valproic acidpathway: pharmacokinetics and pharmacodynamics [J]. Phar-macog Genom,2013,23(4): 236-241. 被引量:1
  • 3Amini-Shirazi N,Ahmadkhaniha R,Shadnia al. Determi-nation of VP A and its two important metabolites in iranian o-verdosed patients[J]. Inter J Pharmacol, 2010,6(6) :854-862. 被引量:1
  • 4Dupuis RE’Lichtman SN, Pollack GM. Acute valproic acid o-verdose : Clinical course and pharmacokinetic disposition of val-proic acid and Metabolites [J〕. Drug Saf,1990,5(1): 65-71. 被引量:1
  • 5Loscher W,Nau Htetal. Valproic acid; metabolite concentra-tions in plasma and brain,antic- onvulsant activity and effectson GABA metabolism during subacute treatment in mice[J].Arch Int Pharmacodyn Ther,1982,257(1) :20-31. 被引量:1
  • 6Andrew S, Davison, Anna M, etal. The consequences of val-proate overdose [J]. Clinical Chemistry, 2011,57(9): 1233-1238. 被引量:1
  • 7Mock CM, Schwetschenau KH. Levocarnitine for valproicacid-induced hyperammonemic encephalopathy [ J ]. Am JHealth Syst Pharm, 2012,69(21) : 35-39. 被引量:1
  • 8Lewis C,Deshpande A, Tesar GE,et al. Valproate-inducedhyperainnionemic encephalopathy : a brief review[J]. Curr MedResOpin,2012,28(6); 1039-1042. 被引量:1
  • 9Otoul C, De Smedt H, Stockis A. Lack of pharmacokinetic in-teraction of LEV on carbamazepine,valproic acid, topiramate,and lamotrigine in children with epilepsy[J]. Epilepsia, 2007,48(11):2111-2115. 被引量:1
  • 10Roh SY, Jang HS, Jeong EH, et al. Valproic acid-induced hy-perammonemic encephalopathy promoted by levetiracetam [J].J Epilepsy Res, 2014,4(2) :82-84. 被引量:1

共引文献81

同被引文献27

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部